Your browser is no longer supported. Please, upgrade your browser.
Settings
ENDP Endo International plc daily Stock Chart
ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-14.47 Insider Own0.20% Shs Outstand224.66M Perf Week10.50%
Market Cap2.55B Forward P/E3.24 EPS next Y3.50 Insider Trans-3.65% Shs Float221.57M Perf Month-0.79%
Income-3223.80M PEG- EPS next Q1.10 Inst Own89.50% Short Float10.83% Perf Quarter-3.48%
Sales4.01B P/S0.64 EPS this Y-850.90% Inst Trans-10.35% Short Ratio2.72 Perf Half Y-45.28%
Book/sh12.12 P/B0.94 EPS next Y-2.69% ROA-19.50% Target Price16.78 Perf Year-59.78%
Cash/sh2.30 P/C4.94 EPS next 5Y-2.90% ROE-63.90% 52W Range9.70 - 29.48 Perf YTD-30.97%
Dividend- P/FCF7.20 EPS past 5Y-61.60% ROI-25.30% 52W High-61.43% Beta0.60
Dividend %- Quick Ratio0.80 Sales past 5Y9.70% Gross Margin34.30% 52W Low17.22% ATR0.53
Employees4894 Current Ratio1.00 Sales Q/Q15.60% Oper. Margin-86.60% RSI (14)53.67 Volatility4.79% 4.88%
OptionableYes Debt/Eq3.06 EPS Q/Q-855.30% Profit Margin-83.50% Rel Volume0.75 Prev Close11.28
ShortableYes LT Debt/Eq3.01 EarningsMay 30 BMO Payout- Avg Volume8.83M Price11.37
Recom2.50 SMA203.82% SMA500.39% SMA200-29.56% Volume6,597,549 Change0.80%
Feb-22-17Initiated Canaccord Genuity Hold $14
Jan-31-17Reiterated Mizuho Buy $25 → $15
Jan-20-17Downgrade JP Morgan Overweight → Neutral
Jan-05-17Downgrade Citigroup Buy → Neutral
Dec-07-16Resumed Oppenheimer Perform
Nov-11-16Reiterated Mizuho Buy $29 → $25
Nov-10-16Upgrade Susquehanna Neutral → Positive
Nov-09-16Reiterated RBC Capital Mkts Outperform $26 → $21
Sep-29-16Upgrade Northland Capital Market Perform → Outperform
Aug-12-16Upgrade Mizuho Neutral → Buy $16 → $29
Jun-13-16Upgrade Mizuho Underperform → Neutral $13 → $16
Jun-06-16Initiated Goldman Neutral $20
May-18-16Reiterated Stifel Buy $75 → $25
May-09-16Reiterated Deutsche Bank Buy $61 → $31
May-06-16Reiterated Stifel Buy $90 → $75
May-06-16Reiterated Barclays Equal Weight $37 → $28
May-06-16Downgrade Piper Jaffray Overweight → Neutral
May-06-16Downgrade Mizuho Neutral → Underperform $42 → $13
May-06-16Downgrade Leerink Partners Outperform → Mkt Perform
Apr-21-16Initiated JMP Securities Mkt Outperform
Apr-27-17 06:02PM  These are the only 9 stocks Morningstar is fully bullish on MarketWatch
Apr-26-17 08:28PM  There are only nine five-star U.S. stocks, but dont panic: Morningstar CEO MarketWatch
Apr-25-17 07:30AM  Endo to Announce First-Quarter 2017 Financial Results PR Newswire
Apr-20-17 09:44AM  Biotech Movers: Organovo, Endo, Omeros TheStreet.com
Apr-13-17 05:51PM  Which Drugmakers Will Rock The Sector In Q1? Investor's Business Daily
12:05PM  Endo International plc -- Moody's rates Endo's new secured notes Ba2 Moody's
08:43AM  Are Options Traders Betting on a Big Move in Endo International (ENDP) Stock? Zacks
Apr-12-17 07:19PM  Endo International plc Announces Pricing of Private Offering of Senior Secured Notes PR Newswire
07:19PM  Endo International plc Announces Pricing of Private Offering of Senior Secured Notes CNW Group
Apr-11-17 05:46PM  Endo (ENDP) Reports Preliminary Results for First Quarter Zacks -9.35%
04:41PM  Why AmTrust Financial Services, Endo International, and Hub Group Slumped Today Motley Fool
Apr-10-17 06:23PM  Endo Finance LLC -- Moody's rates Endo's new secured notes Ba2 Moody's
01:27PM  Endo International plc Announces Proposed Private Offering of Senior Secured Notes PR Newswire
01:27PM  Endo International plc Announces Proposed Private Offering of Senior Secured Notes CNW Group
08:14AM  Endo International Plc breached its 50 day moving average in a Bullish Manner : ENDP-US : April 10, 2017 Capital Cube
Apr-07-17 09:25AM  Endo international, AngioDynamics Lead Biotech Movers TheStreet.com
Apr-05-17 07:30AM  Endo International plc Announces Plan to Refinance Existing Credit Agreement PR Newswire
07:30AM  Endo International plc Announces Plan to Refinance Existing Credit Agreement
Apr-04-17 07:00PM  Endo Luxembourg Finance I Company S.a.r.l. -- Moody's downgrades Endo's CFR to B2; assigns Ba2 to new secured debt Moody's
07:00PM  Endo Luxembourg Finance I Company S.a.r.l. -- Moody's downgrades Endo's CFR to B2; assigns Ba2 to new secured debt
Mar-31-17 03:20AM  Why Is Endo (ENDP) Down 10.6% Since the Last Earnings Report? Zacks
03:20AM  Why Is Endo (ENDP) Down 10.6% Since the Last Earnings Report?
Mar-30-17 04:59PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-28-17 05:51PM  Will Endo's Troubles Continue to Dent Performance in 2017? Zacks
05:51PM  Will Endo's Troubles Continue to Dent Performance in 2017?
05:51PM  Will Endo's Troubles Continue to Dent Performance in 2017? at Investopedia
11:11AM  VIVUS to Regain Commercial Rights for Stendra from Sanofi
Mar-27-17 01:32PM  Shire: Can It Pay Down Debt? Barrons.com +5.32%
01:32PM  Shire: Can It Pay Down Debt? at Barrons.com
Mar-22-17 09:23AM  Billionaires' Worst Healthcare Stock Picks for 2017 (So Far) Motley Fool
09:23AM  Billionaires' Worst Healthcare Stock Picks for 2017 (So Far) at Motley Fool
Mar-20-17 10:10AM  BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet Zacks
10:10AM  BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet
Mar-17-17 09:27AM  Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded
Mar-16-17 07:07PM  Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA Zacks
07:07PM  Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA
Mar-15-17 04:04PM  Frontier Communications, Rubicon Project Plunge into Wednesdays 52-Week Low Club 24/7 Wall St.
04:04PM  Frontier Communications, Rubicon Project Plunge into Wednesdays 52-Week Low Club
11:05AM  FDA panel: Endo opioid painkiller's risks outweigh its benefits at bizjournals.com
10:38AM  How Endo's FDA Committee Vote Affects Egalet
12:29AM  [$$] FDA Advisory Panel Says Benefits of Painkiller Opana ER No Longer Outweigh Risks at The Wall Street Journal
Mar-14-17 08:48PM  Endo Statement On FDA Advisory Committees' Vote Related To OPANA® ER PR Newswire
08:28PM  FDA deals blow to Endo over Opana ER Pain Med
05:35PM  Risks of Endo's opioid painkiller outweigh benefits: FDA panel
05:29PM  [$$] FDA Panel: Painkiller Opana ER Benefits No Longer Outweigh Risks at The Wall Street Journal
04:02PM  FDA: Risk of Endo's opioid painkiller outweigh benefits
03:51PM  Risk of Endo's opioid painkiller outweigh benefits: FDA Panel
Mar-09-17 09:05AM  New Strong Sell Stocks for March 9th
Mar-08-17 08:37AM  Why Endo International (ENDP) Could Be Positioned for a Slump
08:29AM  Trumps Tweets Trigger a Sell-Off in the Healthcare Sector
Mar-07-17 01:04PM  ENDO INTERNATIONAL PLC Financials
12:51PM  Supernus, Valeant, Endo Stocks Lose Big After Trump Drug-Pricing Tweet
Mar-06-17 04:22PM  Has Biodelivery Sciences Finally Turned the Corner? at Motley Fool -6.94%
01:36PM  ETFs with exposure to Endo International Plc : March 6, 2017
Mar-03-17 04:30PM  Endo International plc To Delist Ordinary Shares From The Toronto Stock Exchange PR Newswire
Mar-02-17 12:16PM  Endo International Plc :ENDP-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017
Mar-01-17 02:23PM  ENDO INTERNATIONAL PLC Files SEC form 10-K, Annual Report -6.08%
09:47AM  Endo International Plc :ENDP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 1, 2017
Feb-28-17 05:09PM  Edited Transcript of ENDP earnings conference call or presentation 28-Feb-17 1:30pm GMT
12:17PM  Endo (ENDP) Beats on Q4 Earnings, Revenues; Guides Low
10:55AM  Endo profit, sales beat as the drugmaker enters transition phase
10:46AM  Aytu BioScience May Lead the Way in Low T
08:30AM  Endo International PLC Earnings Call scheduled for 8:30 am ET today
08:23AM  Endo (ENDP) Q4 Earnings & Revenues Beat Estimates
07:22AM  Endo reports 4Q loss
07:07AM  Q4 2016 Endo International PLC Earnings Release - Before Market Open
07:00AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
06:44AM  Endo Pharma revenue rises 15.6 pct
06:30AM  Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results PR Newswire
Feb-27-17 10:12AM  On Generic Drugs, Patent 'Death Squads' And The Oscars at Forbes
Feb-24-17 10:43PM  Endo Pharmaceuticals Inc. Issues Voluntary Nationwide Recall for One Lot of Edex® (alprostadil for injection) 10 mcg 2 Pack Carton Due to Potential Lack of Sterility Assurance PR Newswire
08:43AM  Implied Volatility Surging for Endo International (ENDP) Stock Options
Feb-23-17 05:57PM  Incyte, CBOE Holdings, Regency Centers Set to Join S&P 500; Others to Join S&P MidCap 400 PR Newswire
Feb-22-17 05:16PM  Endo (ENDP) to Post Q4 Earnings: Will the Stock Disappoint?
10:23AM  Coverage initiated on Endo Intl by Canaccord Genuity
Feb-16-17 08:04AM  Health Care Sector Led the S&P 500s Rally on February 15
Feb-13-17 07:30AM  Endo to Announce Fourth-Quarter and Full-Year 2016 Financial Results PR Newswire
Feb-10-17 12:00PM  Is More Downside Ahead For Teva Pharmaceutical? at Barrons.com
Feb-08-17 01:42PM  Canada's TMX seeks part of Saudi Aramco listing Reuters
Feb-06-17 08:35PM  BioMarin sues to stop generic version of its $90K-a-year drug at bizjournals.com
Feb-01-17 04:18PM  Belbuca return expected to push BDSI to profitability sooner at bizjournals.com
Jan-31-17 05:40PM  Endo's (ENDP) Ephedrine Sulfate Injection Gets FDA Approval
10:44AM  Endo International: We Believe? at Barrons.com
Jan-30-17 05:26PM  Endo Announces U.S. FDA Approval of Ephedrine Sulfate Injection, USP PR Newswire
04:19PM  Endo (ENDP) Restructures Branded Pharmaceutical Unit (revised)
Jan-27-17 09:05AM  Endo (ENDP) Restructures its Branded Pharmaceutical Unit
08:58AM  New Strong Sell Stocks for January 27th
Jan-26-17 03:18PM  Weitz Funds Comments on Endo International
06:52AM  Endo to cut 90 jobs as part of drugmaker's restructuring at MarketWatch
06:49AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Financial Statements an
06:30AM  Endo Announces Actions to Drive Greater Efficiency and Business Alignment PR Newswire
Jan-25-17 10:30AM  Endo Settles FTC 'Pay-for-Delay' Allegations at Investopedia
Jan-24-17 09:50AM  Endo (ENDP) Settles Disputes with Federal Trade Commission
09:26AM  Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo
Jan-23-17 06:28PM  U.S. reaches settlement with Endo on pay-for-delay charges Reuters
04:27PM  Endo Resolves FTC Antitrust Suit, But Allergan Hanging; Stocks Mixed
04:10PM  FTC, Endo propose agreement to resolve pay-for-delay dispute at bizjournals.com
04:04PM  Teva, Gilead Sciences Tumble into Mondays 52-Week Low Club
02:49PM  Allergan Stock is Still Struggling Amid FTC Ruling at Investopedia
02:42PM  FTC settles pay-for-delay lawsuit, files two related complaints Reuters
Endo International plc develops, manufactures, and distributes pharmaceutical products and devices worldwide. Its U.S. Generic Pharmaceuticals segment provides tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics, and transdermal patches for pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's U.S. Branded Pharmaceuticals segment offers pain management products, such as Lidoderm, OPAN ER, Percocet, and Voltare Gel. This segment also provides Supprelin LA for central precocious puberty treatment; XIAFLEX for treating Peyronie's and Dupuytren's contracture diseases; Fortesta Gel for hypogonadism treatment; Testim Gel for the treatment of endogenous testosterone; Frova for migraine headaches; Valstar, a sterile solution for intravesical instillation of valrubicin; Vantas for the palliative treatment of prostate cancer; Aveed for the treatment of low testosterone; TESTOPEL, a long-acting implantable pellet; and NASCOBAL, a nasal spray. Its International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, and oncology; generic, branded generic, and over-the-counter products in the areas of dermatology and anti-infectives; and healthcare services, products, and solutions to hospitals, pharmacies, and practitioners, as well as for government healthcare programs. The company also provides injectables for the treatment of pain, anti-infectives, cardiovascular, and other therapeutics areas. It sells its branded pharmaceuticals and generics directly, as well as through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Campanelli PaulPresident, CEOMar 16Buy10.722,30024,656207,120Mar 16 05:54 PM
Hutson Nancy JDirectorMar 09Sale10.825,32557,61731,252Mar 10 10:24 AM
KIMMEL ROGER HDirectorNov 15Sale17.387,000121,632188,000Nov 16 02:00 PM
KIMMEL ROGER HDirectorNov 15Sale17.387,000121,63268,362Nov 16 02:00 PM